Literature DB >> 26203911

Structural Brain Changes in Patients With COPD.

Roland W Esser1, M Cornelia Stoeckel1, Anne Kirsten2, Henrik Watz2, Karin Taube3, Kirsten Lehmann3, Sibylle Petersen4, Helgo Magnussen2, Andreas von Leupoldt5.   

Abstract

BACKGROUND: Patients with COPD suffer from chronic dyspnea, which is commonly perceived as highly aversive and threatening. Moreover, COPD is often accompanied by disease-specific fears and avoidance of physical activity. However, little is known about structural brain changes in patients with COPD and respective relations with disease duration and disease-specific fears.
METHODS: This study investigated structural brain changes in patients with COPD and their relation with disease duration, fear of dyspnea, and fear of physical activity. We used voxel-based morphometric analysis of MRI images to measure differences in generalized cortical degeneration and regional gray matter between 30 patients with moderate to severe COPD and 30 matched healthy control subjects. Disease-specific fears were assessed by the COPD anxiety questionnaire.
RESULTS: Patients with COPD showed no generalized cortical degeneration, but decreased gray matter in posterior cingulate cortex (whole-brain analysis) as well as in anterior and midcingulate cortex, hippocampus, and amygdala (regions-of-interest analyses). Patients' reductions in gray matter in anterior cingulate cortex were negatively correlated with disease duration, fear of dyspnea, and fear of physical activity. Mediation analysis revealed that the relation between disease duration and reduced gray matter of the anterior cingulate was mediated by fear of physical activity.
CONCLUSIONS: Patients with COPD demonstrated gray matter decreases in brain areas relevant for the processing of dyspnea, fear, and antinociception. These structural brain changes were partly related to longer disease duration and greater disease-specific fears, which might contribute to a less favorable course of the disease.
Copyright © 2016 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  COPD; MRI; dyspnea; psychology

Mesh:

Year:  2016        PMID: 26203911     DOI: 10.1378/chest.15-0027

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  26 in total

1.  Altered Gray Matter Volume in Stable Chronic Obstructive Pulmonary Disease with Subclinical Cognitive Impairment: an Exploratory Study.

Authors:  Chunrong Wang; Yanhui Ding; Bixian Shen; Dehong Gao; Jie An; Kewen Peng; Gangqiang Hou; Liqiu Zou; Mei Jiang; Shijun Qiu
Journal:  Neurotox Res       Date:  2016-12-22       Impact factor: 3.911

2.  A low postabsorptive whole body protein balance is associated with markers of poor daily physical functioning in Chronic Obstructive Pulmonary Disease.

Authors:  Clayton L Cruthirds; Nicolaas E P Deutz; Rajesh Harrykissoon; Anthony J Zachria; Mariëlle P K J Engelen
Journal:  Clin Nutr       Date:  2022-03-03       Impact factor: 7.324

3.  Assessment of the mind in chronic obstructive pulmonary disease: Mind or never mind.

Authors:  Bharat Bhushan Sharma; Virendra Singh
Journal:  Lung India       Date:  2016 Mar-Apr

Review 4.  Inspiring change: humanities and social science insights into the experience and management of breathlessness.

Authors:  Rebecca Oxley; Jane Macnaughton
Journal:  Curr Opin Support Palliat Care       Date:  2016-09       Impact factor: 2.302

5.  Brain Responses during the Anticipation of Dyspnea.

Authors:  M Cornelia Stoeckel; Roland W Esser; Matthias Gamer; Christian Büchel; Andreas von Leupoldt
Journal:  Neural Plast       Date:  2016-08-28       Impact factor: 3.599

6.  Brain Activation during Perception and Anticipation of Dyspnea in Chronic Obstructive Pulmonary Disease.

Authors:  Roland W Esser; Maria C Stoeckel; Anne Kirsten; Henrik Watz; Karin Taube; Kirsten Lehmann; Helgo Magnussen; Christian Büchel; Andreas von Leupoldt
Journal:  Front Physiol       Date:  2017-08-23       Impact factor: 4.566

7.  White matter lesions characterise brain involvement in moderate to severe chronic obstructive pulmonary disease, but cerebral atrophy does not.

Authors:  Catherine A Spilling; Paul W Jones; James W Dodd; Thomas R Barrick
Journal:  BMC Pulm Med       Date:  2017-06-19       Impact factor: 3.317

Review 8.  Pathophysiology of Brain Injury and Neurological Outcome in Acute Respiratory Distress Syndrome: A Scoping Review of Preclinical to Clinical Studies.

Authors:  Merry Huang; Aron Gedansky; Catherine E Hassett; Carrie Price; Tracey H Fan; R Scott Stephens; Paul Nyquist; Ken Uchino; Sung-Min Cho
Journal:  Neurocrit Care       Date:  2021-07-23       Impact factor: 3.210

9.  Cystic Fibrosis, New Frontier: Exploring the Functional Connectivity of the Brain Default Mode Network. Comment on Elce et al. Impact of Physical Activity on Cognitive Functions: A New Field for Research and Management of Cystic Fibrosis. Diagnostics 2020, 10, 489.

Authors:  Simone Gambazza; Rita Maria Nobili; Riccardo Biffi; Paul Eugene Summers; Carla Colombo; Antonella Costa
Journal:  Diagnostics (Basel)       Date:  2021-05-31

Review 10.  What else should we know about experiencing COPD? A narrative review in search of patients' psychological burden alleviation.

Authors:  Marta Rzadkiewicz; Ola Bråtas; Geir Arild Espnes
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-09-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.